These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 19369177
1. Association of the 3' region of COMT with schizophrenia in Taiwan. Chien YL, Liu CM, Fann CS, Liu YL, Hwu HG. J Formos Med Assoc; 2009 Apr; 108(4):301-9. PubMed ID: 19369177 [Abstract] [Full Text] [Related]
3. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS. Mol Psychiatry; 2004 Oct; 9(10):962-7. PubMed ID: 15124004 [Abstract] [Full Text] [Related]
4. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I. Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207 [Abstract] [Full Text] [Related]
5. Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls. Matsuzaka CT, Christofolini D, Ota VK, Gadelha A, Berberian AA, Noto C, Mazzotti DR, Spindola LM, Moretti PN, Smith MAC, Melaragno MI, Belangero SI, Bressan RA. Braz J Psychiatry; 2017 Jul; 39(4):302-308. PubMed ID: 28273278 [Abstract] [Full Text] [Related]
6. Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia. Liao SY, Lin SH, Liu CM, Hsieh MH, Hwang TJ, Liu SK, Guo SC, Hwu HG, Chen WJ. Genes Brain Behav; 2009 Mar; 8(2):228-37. PubMed ID: 19077118 [Abstract] [Full Text] [Related]
7. Association between COMT gene polymorphisms, clinical symptoms, and cognitive functions in Han Chinese patients with schizophrenia. Sun Z, Zhang Z, Mao P, Ma Y, Li W, Li J, Yang X, Ling S, Tang Y. Psychiatr Genet; 2018 Jun; 28(3):47-54. PubMed ID: 29634613 [Abstract] [Full Text] [Related]
8. Association analysis of COMT polymorphisms and schizophrenia in a Chinese Han population: a case-control study. Yu R, Zhang XN, Huang XX, Ding SP, Li JC. Am J Med Genet B Neuropsychiatr Genet; 2007 Jun 05; 144B(4):570-3. PubMed ID: 17427186 [Abstract] [Full Text] [Related]
9. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Handoko HY, Nyholt DR, Hayward NK, Nertney DA, Hannah DE, Windus LC, McCormack CM, Smith HJ, Filippich C, James MR, Mowry BJ. Mol Psychiatry; 2005 Jun 05; 10(6):589-97. PubMed ID: 15505638 [Abstract] [Full Text] [Related]
10. Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aki H, Sumitani S, Itakura M, Ohmori T. J Neural Transm (Vienna); 2007 Feb 05; 114(2):255-9. PubMed ID: 16897602 [Abstract] [Full Text] [Related]
11. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Nicodemus KK, Kolachana BS, Vakkalanka R, Straub RE, Giegling I, Egan MF, Rujescu D, Weinberger DR. Hum Genet; 2007 Feb 05; 120(6):889-906. PubMed ID: 17006672 [Abstract] [Full Text] [Related]
12. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Sazci A, Ergul E, Kucukali I, Kilic G, Kaya G, Kara I. Brain Res Mol Brain Res; 2004 Dec 06; 132(1):51-6. PubMed ID: 15548428 [Abstract] [Full Text] [Related]
13. Association of Single Nucleotide Polymorphisms in Catechol-O-Methyltransferase and Serine-Threonine Protein Kinase Genes in the Pakistani Schizophrenic Population: A Study with Special Emphasis on Cannabis and Smokeless Tobacco. Nawaz R, Siddiqui S. CNS Neurol Disord Drug Targets; 2015 Dec 06; 14(8):1086-95. PubMed ID: 25801838 [Abstract] [Full Text] [Related]
14. A quantitative association study between schizotypal traits and COMT, PRODH and BDNF genes in a healthy Chinese population. Ma X, Sun J, Yao J, Wang Q, Hu X, Deng W, Sun X, Liu X, Murray RM, Collier DA, Li T. Psychiatry Res; 2007 Sep 30; 153(1):7-15. PubMed ID: 17604122 [Abstract] [Full Text] [Related]
15. No association between catechol-o-methyltransferase Val108/158Met polymorphism and schizophrenia or its clinical symptomatology in a Mexican population. Tovilla-Zárate C, Medellín BC, Fresán A, López-Narváez L, Castro TB, Juárez Rojop I, Ramírez-Bello J, Genis A, Nicolini H. Mol Biol Rep; 2013 Feb 30; 40(2):2053-8. PubMed ID: 23184041 [Abstract] [Full Text] [Related]
16. Association between catechol-O-methyltrasferase Val108/158Met genotype and prefrontal hemodynamic response in schizophrenia. Takizawa R, Tochigi M, Kawakubo Y, Marumo K, Sasaki T, Fukuda M, Kasai K. PLoS One; 2009 Feb 30; 4(5):e5495. PubMed ID: 19424500 [Abstract] [Full Text] [Related]
17. The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on 32,816 Subjects. González-Castro TB, Hernández-Díaz Y, Juárez-Rojop IE, López-Narváez ML, Tovilla-Zárate CA, Fresan A. Neuromolecular Med; 2016 Jun 30; 18(2):216-31. PubMed ID: 27020768 [Abstract] [Full Text] [Related]
18. Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophrenia. Higashiyama R, Ohnuma T, Takebayashi Y, Hanzawa R, Shibata N, Yamamori H, Yasuda Y, Kushima I, Aleksic B, Kondo K, Ikeda M, Hashimoto R, Iwata N, Ozaki N, Arai H. Am J Med Genet B Neuropsychiatr Genet; 2016 Apr 30; 171B(3):447-57. PubMed ID: 26852906 [Abstract] [Full Text] [Related]
19. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Woodward ND, Jayathilake K, Meltzer HY. Schizophr Res; 2007 Feb 30; 90(1-3):86-96. PubMed ID: 17123785 [Abstract] [Full Text] [Related]
20. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. Molero P, Ortuño F, Zalacain M, Patiño-García A. Pharmacogenomics J; 2007 Dec 30; 7(6):418-26. PubMed ID: 17363961 [Abstract] [Full Text] [Related] Page: [Next] [New Search]